Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Pediatric Rheumatology Online Journal|December 6, 2018
Protective parents and permissive children: what qualitative interviews with parents and children can tell us about the feasibility of juvenile idiopathic arthritis trialsFrances C Sherratt, Louise Roper, Simon R Stones, et al.
Ocular Immunology and Inflammation|February 21, 2023
Clinical Efficacy of Biosimilar Switch of Adalimumab for Management of UveitisG M Murray, N Griffith, P Sinnappurajar, et al.
Pediatric Rheumatology Online Journal|June 11, 2020
Artificial intelligence for interpretation of segments of whole body MRI in CNO: pilot study comparing radiologists versus machine learning algorithmChandrika S Bhat, Mark Chopra, Savvas Andronikou, et al.
The Lancet. Rheumatology|March 5, 2026
Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumabAthimalaipet V Ramanan, Nicolino Ruperto, Ivan Foeldvari, et al.
Frontiers in Ophthalmology|July 10, 2024
Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseasesAlex Fonollosa, Ester Carreño, Antonio Vitale, et al.
Trials|January 11, 2014
A randomised controlled trial of the clinical effectiveness, safety and cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial)Athimalaipet V Ramanan, Andrew D Dick, Diana Benton, et al.
Rheumatology (Oxford, England)|February 25, 2021
'It is good to have a target in mind': qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosusEve M D Smith, Sarah L Gorst, Eslam Al-Abadi, et al.
The Journal of Rheumatology|September 17, 2016
Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic ArthritisChristoph Tappeiner, Marina Mesquida, Alfredo Adán, et al.
Rheumatology (Oxford, England)|August 21, 2024
Incidence of chronic recurrent multifocal osteomyelitis in children and adolescents in the UK and Republic of IrelandDaphne Theresa Chia, Andoni Paul Toms, Anish Sanghrajka, et al.
Lancet (London, England)|July 9, 2023
Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trialAthimalaipet V Ramanan, Pierre Quartier, Nami Okamoto, et al.
Pageof 16